NCT00243074 · OUTCOME

Overall Survival

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2018-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: months
Interval / dispersion: 95% Confidence Interval
Time frame: Daily during protocol treatment; then every 8 weeks until progression; then every 6 months for up to 3 years.

What was measured

From the date of enrollment until the date of death due to any cause. Patients last known to be alive were censored at the date of last contact.

Analysis population: Eligible patients who received AZD2171

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
AZD2171	47

Source class 1

Values in months · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
AZD2171	9.5	Not reported	5.6	10.7	Not reported

Complete source fields

classes

denoms

description

From the date of enrollment until the date of death due to any cause. Patients last known to be alive were censored at the date of last contact.

dispersion Type

95% Confidence Interval

groups

param Type

MEDIAN

population Description

Eligible patients who received AZD2171

reporting Status

POSTED

time Frame

Daily during protocol treatment; then every 8 weeks until progression; then every 6 months for up to 3 years.

title

Overall Survival

type

SECONDARY

unit Of Measure

months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice